Glucocorticoid receptor alpha translational isoforms as mediators of early adversities and negative emotional states
Authorized Users Only
Nešić, Milica J.
Petrović, Zorica D.
Soldatović, Ivan A.
Marić, Nađa P.
Article (Published version)
© 2018 Elsevier Inc
MetadataShow full item record
Childhood trauma (CT) increases the risk for psychopathology through disturbed acquisition and extinction of fear. The effects of CT are mediated by abnormalities of the hypothalamic-pituitary-adrenal axis and glucocorticoid receptor (GR). Since, the alterations in GRα translational isoforms have been documented in psychiatric disorders we sought to: 1) explore whether multiple GRα isoforms in the human peripheral blood mononuclear cells of two independent cohorts (whole cell n = 40; and nuclear extracts n = 43, adult subjects) mediate the effect of CT on negative affectivity (NA) measured by Depression, Anxiety and Stress Scales (DASS), and 2) examine their role/function during fear extinction in the animal model. In multiple regression analysis, CT, nuclear 40-kDa GRα their interactions and FKBP5 explained 22%–35% of variance in DASS scores. Structural equation modeling showed that CT had a significant direct effect on 40-kDa and DASS in both cohorts, and on the nuclear 25-kDa GRα. T...he association between 40-kDa and total DASS was significantly mediated by nuclear FKBP5, whereas on DASS anxiety, over FKBP5 in both cohorts and nuclear full length GRα. Nuclear 40-kDa GRα and its interaction with CT had a significant direct effect on DASS anxiety. In mice, the successful extinction learning was followed by nuclear translocation of 40-kDa GRα and induction of BDNF exon IV expression. Our data revealed that the association between CT and adult NA in non-clinical subjects is mediated by the GRα translational isoforms, in particular 40-kDa GRα and emphasized its role in fear extinction and neural plasticity. © 2018 Elsevier Inc.
Keywords:Childhood trauma / Glucocorticoid receptor / Fear conditioning / Plasticity
Source:Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2019, 90, 288-299
- Defining a cluster of molecular biomarkers for improved diagnostics and therapy of mood disorders (RS-41029)
- NIH grant (R21MH098793)
ISSN: 0278-5846 (print); 1878-4216 (electronic)